A radiogallium-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging

Kohei Sano, Ryo Masuda, Hayato Hisada, Shinya Oishi, Kenta Shimokawa, Masahiro Ono, Nobutaka Fujii, Hideo Saji, Takahiro Mukai

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We have developed a novel radiogallium (Ga)-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging. A CXCR4 imaging probe with two CXCR4 antagonists (Ac-TZ14011) on Ga-DOTA core, Ga-DOTA-TZ2, was synthesized, and the affinity and binding to CXCR4 was evaluated in CXCR4 expressing cells in vitro. The affinity of Ga-DOTA-TZ2 for CXCR4 was 20-fold greater than the corresponding monovalent probe, Ga-DOTA-TZ1. 67Ga-DOTA-TZ2 showed the significantly higher accumulation in CXCR4-expressing tumor cells compared with 67Ga-DOTA-TZ1, suggesting the bivalent effect enhances its binding to CXCR4. The incorporation of two CXCR4 antagonists to Ga-DOTA could be effective in detecting CXCR4-expressing tumors.

Original languageEnglish
Pages (from-to)1386-1388
Number of pages3
JournalBioorganic and Medicinal Chemistry Letters
Volume24
Issue number5
DOIs
Publication statusPublished - 2014 Mar 1
Externally publishedYes

Fingerprint

Chemokine Receptors
Tumors
Ligands
Imaging techniques
Neoplasms
Cells

Keywords

  • Bivalent effect
  • CXCR4
  • DOTA
  • Radiogallium

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

A radiogallium-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging. / Sano, Kohei; Masuda, Ryo; Hisada, Hayato; Oishi, Shinya; Shimokawa, Kenta; Ono, Masahiro; Fujii, Nobutaka; Saji, Hideo; Mukai, Takahiro.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 24, No. 5, 01.03.2014, p. 1386-1388.

Research output: Contribution to journalArticle

Sano, Kohei ; Masuda, Ryo ; Hisada, Hayato ; Oishi, Shinya ; Shimokawa, Kenta ; Ono, Masahiro ; Fujii, Nobutaka ; Saji, Hideo ; Mukai, Takahiro. / A radiogallium-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging. In: Bioorganic and Medicinal Chemistry Letters. 2014 ; Vol. 24, No. 5. pp. 1386-1388.
@article{723a2311bbdb4df0ad5e70f7543a05d4,
title = "A radiogallium-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging",
abstract = "We have developed a novel radiogallium (Ga)-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging. A CXCR4 imaging probe with two CXCR4 antagonists (Ac-TZ14011) on Ga-DOTA core, Ga-DOTA-TZ2, was synthesized, and the affinity and binding to CXCR4 was evaluated in CXCR4 expressing cells in vitro. The affinity of Ga-DOTA-TZ2 for CXCR4 was 20-fold greater than the corresponding monovalent probe, Ga-DOTA-TZ1. 67Ga-DOTA-TZ2 showed the significantly higher accumulation in CXCR4-expressing tumor cells compared with 67Ga-DOTA-TZ1, suggesting the bivalent effect enhances its binding to CXCR4. The incorporation of two CXCR4 antagonists to Ga-DOTA could be effective in detecting CXCR4-expressing tumors.",
keywords = "Bivalent effect, CXCR4, DOTA, Radiogallium",
author = "Kohei Sano and Ryo Masuda and Hayato Hisada and Shinya Oishi and Kenta Shimokawa and Masahiro Ono and Nobutaka Fujii and Hideo Saji and Takahiro Mukai",
year = "2014",
month = "3",
day = "1",
doi = "10.1016/j.bmcl.2014.01.031",
language = "English",
volume = "24",
pages = "1386--1388",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - A radiogallium-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging

AU - Sano, Kohei

AU - Masuda, Ryo

AU - Hisada, Hayato

AU - Oishi, Shinya

AU - Shimokawa, Kenta

AU - Ono, Masahiro

AU - Fujii, Nobutaka

AU - Saji, Hideo

AU - Mukai, Takahiro

PY - 2014/3/1

Y1 - 2014/3/1

N2 - We have developed a novel radiogallium (Ga)-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging. A CXCR4 imaging probe with two CXCR4 antagonists (Ac-TZ14011) on Ga-DOTA core, Ga-DOTA-TZ2, was synthesized, and the affinity and binding to CXCR4 was evaluated in CXCR4 expressing cells in vitro. The affinity of Ga-DOTA-TZ2 for CXCR4 was 20-fold greater than the corresponding monovalent probe, Ga-DOTA-TZ1. 67Ga-DOTA-TZ2 showed the significantly higher accumulation in CXCR4-expressing tumor cells compared with 67Ga-DOTA-TZ1, suggesting the bivalent effect enhances its binding to CXCR4. The incorporation of two CXCR4 antagonists to Ga-DOTA could be effective in detecting CXCR4-expressing tumors.

AB - We have developed a novel radiogallium (Ga)-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging. A CXCR4 imaging probe with two CXCR4 antagonists (Ac-TZ14011) on Ga-DOTA core, Ga-DOTA-TZ2, was synthesized, and the affinity and binding to CXCR4 was evaluated in CXCR4 expressing cells in vitro. The affinity of Ga-DOTA-TZ2 for CXCR4 was 20-fold greater than the corresponding monovalent probe, Ga-DOTA-TZ1. 67Ga-DOTA-TZ2 showed the significantly higher accumulation in CXCR4-expressing tumor cells compared with 67Ga-DOTA-TZ1, suggesting the bivalent effect enhances its binding to CXCR4. The incorporation of two CXCR4 antagonists to Ga-DOTA could be effective in detecting CXCR4-expressing tumors.

KW - Bivalent effect

KW - CXCR4

KW - DOTA

KW - Radiogallium

UR - http://www.scopus.com/inward/record.url?scp=84894591288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894591288&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2014.01.031

DO - 10.1016/j.bmcl.2014.01.031

M3 - Article

VL - 24

SP - 1386

EP - 1388

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 5

ER -